BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 19961309)

  • 1. Soluble CD70: a novel immunotherapeutic agent for experimental glioblastoma.
    Miller J; Eisele G; Tabatabai G; Aulwurm S; von Kürthy G; Stitz L; Roth P; Weller M
    J Neurosurg; 2010 Aug; 113(2):280-5. PubMed ID: 19961309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of T-cell antitumor immunity and protection against tumor growth by secretion of soluble human CD70 molecules.
    Cormary C; Gonzalez R; Faye JC; Favre G; Tilkin-Mariamé AF
    Cancer Gene Ther; 2004 Jul; 11(7):497-507. PubMed ID: 15153937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune stimulatory effects of CD70 override CD70-mediated immune cell apoptosis in rodent glioma models and confer long-lasting antiglioma immunity in vivo.
    Aulwurm S; Wischhusen J; Friese M; Borst J; Weller M
    Int J Cancer; 2006 Apr; 118(7):1728-35. PubMed ID: 16217761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD27 costimulation contributes substantially to the expansion of functional memory CD8(+) T cells after peptide immunization.
    Taraban VY; Rowley TF; Kerr JP; Willoughby JE; Johnson PM; Al-Shamkhani A; Buchan SL
    Eur J Immunol; 2013 Dec; 43(12):3314-23. PubMed ID: 24002868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal stimulation for CD70 induction on human monocyte-derived dendritic cells and the importance of CD70 in naive CD4(+) T-cell differentiation.
    Arimoto-Miyamoto K; Kadowaki N; Kitawaki T; Iwata S; Morimoto C; Uchiyama T
    Immunology; 2010 May; 130(1):137-49. PubMed ID: 20201989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged survival of mice with glioma injected intracerebrally with double cytokine-secreting cells.
    Lichtor T; Glick RP; Kim TS; Hand R; Cohen EP
    J Neurosurg; 1995 Dec; 83(6):1038-44. PubMed ID: 7490618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of CD70-mediated apoptosis of immune effector cells as a novel immune escape pathway of human glioblastoma.
    Wischhusen J; Jung G; Radovanovic I; Beier C; Steinbach JP; Rimner A; Huang H; Schulz JB; Ohgaki H; Aguzzi A; Rammensee HG; Weller M
    Cancer Res; 2002 May; 62(9):2592-9. PubMed ID: 11980654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD8+ T cells produce the chemokine CXCL10 in response to CD27/CD70 costimulation to promote generation of the CD8+ effector T cell pool.
    Peperzak V; Veraar EA; Xiao Y; Babala N; Thiadens K; Brugmans M; Borst J
    J Immunol; 2013 Sep; 191(6):3025-36. PubMed ID: 23940275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SD-208, a novel transforming growth factor beta receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo.
    Uhl M; Aulwurm S; Wischhusen J; Weiler M; Ma JY; Almirez R; Mangadu R; Liu YW; Platten M; Herrlinger U; Murphy A; Wong DH; Wick W; Higgins LS; Weller M
    Cancer Res; 2004 Nov; 64(21):7954-61. PubMed ID: 15520202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. OX40 ligand expressed in glioblastoma modulates adaptive immunity depending on the microenvironment: a clue for successful immunotherapy.
    Shibahara I; Saito R; Zhang R; Chonan M; Shoji T; Kanamori M; Sonoda Y; Kumabe T; Kanehira M; Kikuchi T; So T; Watanabe T; Takahashi H; Iwabuchi E; Tanaka Y; Shibahara Y; Sasano H; Ishii N; Tominaga T
    Mol Cancer; 2015 Feb; 14():41. PubMed ID: 25744203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD70, a novel target of CAR T-cell therapy for gliomas.
    Jin L; Ge H; Long Y; Yang C; Chang YE; Mu L; Sayour EJ; De Leon G; Wang QJ; Yang JC; Kubilis PS; Bao H; Xia S; Lu D; Kong Y; Hu L; Shang Y; Jiang C; Nie J; Li S; Gu Y; Sun J; Mitchell DA; Lin Z; Huang J
    Neuro Oncol; 2018 Jan; 20(1):55-65. PubMed ID: 28651374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of costimulatory ligand CD70 on steady-state dendritic cells breaks CD8+ T cell tolerance and permits effective immunity.
    Keller AM; Schildknecht A; Xiao Y; van den Broek M; Borst J
    Immunity; 2008 Dec; 29(6):934-46. PubMed ID: 19062317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The expression of CD70 and CD80 by gene-modified tumor cells induces an antitumor response depending on the MHC status.
    Douin-Echinard V; Bornes S; Rochaix P; Tilkin AF; Peron JM; Bonnet J; Favre G; Couderc B
    Cancer Gene Ther; 2000 Dec; 7(12):1543-56. PubMed ID: 11228533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo vaccination with tumor cell lysate plus CpG oligodeoxynucleotides eradicates murine glioblastoma.
    Wu A; Oh S; Gharagozlou S; Vedi RN; Ericson K; Low WC; Chen W; Ohlfest JR
    J Immunother; 2007; 30(8):789-97. PubMed ID: 18049330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coexpression of CD40L and CD70 by semiallogenic tumor cells induces anti-tumor immunity.
    Cormary C; Hiver E; Mariamé B; Favre G; Tilkin-Mariamé AF
    Cancer Gene Ther; 2005 Dec; 12(12):963-72. PubMed ID: 15956983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of CD70 and CD80 intracytoplasmic domains in the co-stimulatory signal required to provide an antitumor immune response.
    Douin-Echinard V; Péron JM; Lauwers-Cancès V; Favre G; Couderc B
    Int Immunol; 2003 Mar; 15(3):359-72. PubMed ID: 12618480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In situ expression of soluble B7-1 in the context of oncolytic herpes simplex virus induces potent antitumor immunity.
    Todo T; Martuza RL; Dallman MJ; Rabkin SD
    Cancer Res; 2001 Jan; 61(1):153-61. PubMed ID: 11196154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD27-CD27 ligand/CD70 interactions enhance alloantigen-induced proliferation and cytolytic activity in CD8+ T lymphocytes.
    Brown GR; Meek K; Nishioka Y; Thiele DL
    J Immunol; 1995 Apr; 154(8):3686-95. PubMed ID: 7706711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allogeneic GM-CSF-secreting tumor cell immunotherapies generate potent anti-tumor responses comparable to autologous tumor cell immunotherapies.
    Li B; Simmons A; Du T; Lin C; Moskalenko M; Gonzalez-Edick M; VanRoey M; Jooss K
    Clin Immunol; 2009 Nov; 133(2):184-97. PubMed ID: 19664962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of antigen-specific immune responses against malignant brain tumors by intramuscular injection of sindbis DNA encoding gp100 and IL-18.
    Yamanaka R; Xanthopoulos KG
    DNA Cell Biol; 2005 May; 24(5):317-24. PubMed ID: 15869409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.